USA Compression Partners, LP USAC
25.54
0.01
0.04%
as of 25 Sep
- Market cap
- $3.7B
- P/E
- 23.9×
Follow USAC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.66 | 27.67 | 27.06 | 29.63 |
+8 more quarters Free account |
P/S ratio |
3.25 | 3.57 | 2.78 | 2.97 | |
P/FCF ratio |
12.24 | 12.69 | 9.95 | 10.06 | |
P/Operating CF |
26.26 | 44.96 | 19.91 | 38.80 | |
P/B ratio |
13.33 | 12.23 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 263.83 | 0.00 | 0.00 | |
EV/Sales |
5.75 | 6.31 | 5.30 | 5.52 | |
EV/EBITDA |
9.92 | 10.58 | 8.71 | 9.08 | |
EV/Operating CF |
15.11 | 16.06 | 13.42 | 14.22 | |
EV/FCF |
21.63 | 22.40 | 18.95 | 18.70 | |
Quick Ratio |
0.59 | 0.74 | 0.48 | 0.55 | |
Current Ratio |
1.35 | 1.55 | 1.27 | 1.36 | |
Net Debt/EBITDA |
15.30 | 16.42 | 16.64 | 16.02 | |
Debt/Assets |
79.83% | 79.81% | 96.34% | 95.12% | |
Debt/Equity |
10.25 | 9.41 | (22.43) | (32.93) | |
Asset Turnover |
0.37 | 0.34 | 0.37 | 0.36 | |
Operating CF/Net income |
3.19 | 2.25 | 5.02 | 2.33 | |
Capex/Depreciation |
(0.40) | (0.26) | (0.69) | (0.32) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.45% | 10.67% | 7.09% | 6.67% | |
Intangible Assets out of Total Assets |
0.08 | 0.08 | 0.07 | 0.07 | |
Share Based Compensation of Revenue |
0.47% | 0.73% | 0.60% | 0.47% | |
Graham Net Nets |
(0.80) | (0.79) | (0.90) | (0.84) | |
Graham Number |
6.90 | 6.99 | 0.00 | 0.00 | |
Earnings Yield |
4.05% | 3.61% | 3.70% | 3.38% | |
Free Cash Flow Yield |
8.17% | 7.88% | 10.05% | 9.94% | |
Revenue per Share |
2.36 | 2.32 | 2.09 | 2.04 | |
Operating CF per Share |
1.00 | 0.60 | 1.16 | 0.62 | |
Capex per Share |
(0.25) | (0.17) | (0.42) | (0.19) | |
Free Cash Flow per Share |
0.75 | 0.44 | 0.73 | 0.43 | |
Cash per Share |
0.07 | 0.10 | 0.07 | 0.00 | |
Shareholders Equity per Share |
1.98 | 2.22 | (0.93) | (0.63) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.98 | 2.22 | (0.93) | (0.63) | |
Free Cash Flow |
109.25 | 62.48 | 88.31 | 52.50 | |
Working Capital |
82.91 | 122.60 | 49.66 | 66.79 | |
Capital Expenditures |
(36.44) | (23.63) | (51.18) | (23.38) | |
Net Current Asset Value |
(3,075.42) | (3,070.93) | (2,495.86) | (2,484.45) | |
EV/EBIT |
19.18 | 20.81 | 17.27 | 17.98 | |
Capex to Sales |
0.11 | 0.07 | 0.20 | 0.09 | |
Net Profit Margin |
13.34% | 11.57% | 10.99% | 13.00% | |
Price to Operating Income |
10.86 | 11.78 | 9.06 | 9.67 | |
| Other line items | |||||
Average Receivables |
112.12 | 123.18 | 84.65 | 99.99 | |
Average Payables |
32.71 | 34.84 | 23.68 | 28.15 | |
Average Inventory |
147.48 | 144.35 | 134.19 | 142.09 | |
Average Assets |
3,178.43 | 3,223.78 | 2,682.77 | 2,731.42 | |
Average Common Equity |
82.83 | 67.98 | (126.78) | (128.73) |
Columns are period end dates